Ms. Parks has been a commercial leader in the biotech and pharma industry for over 30 years. Her commercial leadership included senior roles in marketing, business analytics, sales, and managed care in leading biotech companies including Genentech, Amgen, and Pharmacyclics. Diane’s strategic insights and marketing efforts influenced the launches of blockbuster therapies including Allegra®, Rituxan®, Herceptin®, and Imbruvica®. Prior to joining Kite, Ms. Parks was Vice President of Marketing at Pharmacyclics. During her tenure at Pharmacyclics, she led the development and execution of all global marketing strategies for Imbruvica®. Previously, Ms. Parks held senior leadership roles as Vice President of Sales for Amgen, representing oncology and nephrology products, and Senior Vice President of Specialty Biotherapeutics and Managed Care at Genentech, where she led the launches of multiple products as well as commercial development of Lucentis® and Rituxan®. Ms. Parks began her career at Marion Merrell Dow. She holds a BS from Kansas State University and an MBA from Georgia State University.